CCEL Q3 2020 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q3 2020 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M-1.3% YoY

Gross Profit

$6M70.9% margin

Operating Income

$2M30.6% margin

Net Income

$784,4679.7% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$161,994

Balance Sheet

Total Assets

$44M

Total Liabilities

$48M

Stockholders' Equity

-$4M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	-1.3%
Gross Profit	$6M	$6M	+2.1%
Operating Income	$2M	$2M	+24.4%
Net Income	$784,467	$1M	-29.7%

Revenue Segments

Processing And Storage Fees

$7M92%

Licensee And Royalty Income Recognition

$427,8745%

Public Banking

$116,8261%

Product

$82,8001%